Amanda J. Gerringer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amanda J. Gerringer has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bethany D. Latham
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
1 shared publication Corbin D. Jones
Bioinformatics and Analytics Research Collaborative (BARC), UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Biology, UNC, Department of Genetics, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
1 shared publication- John Kevin Fallon
Division of Pharmacoengineering and Molecular Pharmaceutics, and Center for Nanotechnology in Drug Delivery, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
1 shared publication - Klarissa D. Jackson
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
1 shared publication Pegah Montazeri
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
1 shared publication- Raeanne M. Geffert
Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
1 shared publication
Latest Publications
- 3 November 2025
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 53 (12) , 100196
Interindividual variability in imatinib metabolism in human liver microsomes and primary human hepatocytes: Impact of CYP2C8 and CYP3A phenotypes
- 3 November 2025
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 53 (12) , 100196
Interindividual variability in imatinib metabolism in human liver microsomes and primary human hepatocytes: Impact of CYP2C8 and CYP3A phenotypes